Point72 Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$22.1M Sell
2025
Q3
$47.6M Sell
2025
Q2
$28.2M Buy
2025
Q1
$8.86M Sell
2024
Q4
$16.2M Sell
2024
Q3
$29.4M Sell
2024
Q2
$10.9M Buy
2022
Q2
Sell
2022
Q1
$1.22M Sell
2021
Q4
$1.92M Buy
2021
Q3
$2.78M Buy
2017
Q4
Sell
2017
Q3
$3.11M Sell
2017
Q2
$2.81M Sell
2017
Q1
$8.48M Buy